SBC Medical Group (SBC) Competitors

SBC Medical Group logo
$3.07 +0.12 (+4.07%)
Closing price 04:00 PM Eastern
Extended Trading
$3.12 +0.05 (+1.66%)
As of 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SBC vs. PNTG, OMDA, PSNL, LMRI, and TALK

Should you buy SBC Medical Group stock or one of its competitors? MarketBeat compares SBC Medical Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SBC Medical Group include The Pennant Group (PNTG), Omada Health (OMDA), Personalis (PSNL), Lumexa Imaging (LMRI), and Talkspace (TALK). These companies are all part of the "healthcare" industry.

How does SBC Medical Group compare to The Pennant Group?

SBC Medical Group (NASDAQ:SBC) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

SBC Medical Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market.

60.8% of SBC Medical Group shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by company insiders. Comparatively, 6.9% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, The Pennant Group had 3 more articles in the media than SBC Medical Group. MarketBeat recorded 3 mentions for The Pennant Group and 0 mentions for SBC Medical Group. The Pennant Group's average media sentiment score of 0.24 beat SBC Medical Group's score of 0.00 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Overall Sentiment
SBC Medical Group Neutral
The Pennant Group Neutral

SBC Medical Group currently has a consensus price target of $8.50, suggesting a potential upside of 176.87%. The Pennant Group has a consensus price target of $39.00, suggesting a potential upside of 13.94%. Given SBC Medical Group's higher possible upside, research analysts plainly believe SBC Medical Group is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
The Pennant Group
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.75

SBC Medical Group has a net margin of 24.09% compared to The Pennant Group's net margin of 2.96%. SBC Medical Group's return on equity of 15.90% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
The Pennant Group 2.96%10.07%4.23%

SBC Medical Group has higher earnings, but lower revenue than The Pennant Group. SBC Medical Group is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.87
The Pennant Group$1.02B1.16$29.58M$0.8540.27

Summary

The Pennant Group beats SBC Medical Group on 9 of the 16 factors compared between the two stocks.

How does SBC Medical Group compare to Omada Health?

SBC Medical Group (NASDAQ:SBC) and Omada Health (NASDAQ:OMDA) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 6.4% of Omada Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

SBC Medical Group has higher earnings, but lower revenue than Omada Health. Omada Health is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.87
Omada Health$260.21M4.18-$12.78M-$0.27N/A

In the previous week, Omada Health had 4 more articles in the media than SBC Medical Group. MarketBeat recorded 4 mentions for Omada Health and 0 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.00 beat Omada Health's score of -0.47 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Overall Sentiment
SBC Medical Group Neutral
Omada Health Neutral

SBC Medical Group has a net margin of 24.09% compared to Omada Health's net margin of -2.22%. SBC Medical Group's return on equity of 15.90% beat Omada Health's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
Omada Health -2.22%-1.82%-1.36%

SBC Medical Group presently has a consensus target price of $8.50, suggesting a potential upside of 176.87%. Omada Health has a consensus target price of $22.91, suggesting a potential upside of 25.19%. Given SBC Medical Group's higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Omada Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Omada Health
1 Sell rating(s)
2 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.69

Summary

SBC Medical Group beats Omada Health on 10 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Personalis?

SBC Medical Group (NASDAQ:SBC) and Personalis (NASDAQ:PSNL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

SBC Medical Group has a net margin of 24.09% compared to Personalis' net margin of -148.11%. SBC Medical Group's return on equity of 15.90% beat Personalis' return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
Personalis -148.11%-43.52%-32.92%

SBC Medical Group currently has a consensus target price of $8.50, suggesting a potential upside of 176.87%. Personalis has a consensus target price of $11.00, suggesting a potential upside of 9.34%. Given SBC Medical Group's higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Personalis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Personalis
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 61.9% of Personalis shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 4.2% of Personalis shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

SBC Medical Group has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market. Comparatively, Personalis has a beta of 2.27, meaning that its share price is 127% more volatile than the broader market.

SBC Medical Group has higher revenue and earnings than Personalis. Personalis is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.87
Personalis$64.52M16.33-$81.27M-$1.02N/A

In the previous week, Personalis had 1 more articles in the media than SBC Medical Group. MarketBeat recorded 1 mentions for Personalis and 0 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.00 equaled Personalis'average media sentiment score.

Company Overall Sentiment
SBC Medical Group Neutral
Personalis Neutral

Summary

SBC Medical Group beats Personalis on 9 of the 15 factors compared between the two stocks.

How does SBC Medical Group compare to Lumexa Imaging?

SBC Medical Group (NASDAQ:SBC) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

In the previous week, SBC Medical Group's average media sentiment score of 0.00 equaled Lumexa Imaging'saverage media sentiment score.

Company Overall Sentiment
SBC Medical Group Neutral
Lumexa Imaging Neutral

SBC Medical Group has higher earnings, but lower revenue than Lumexa Imaging.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.87
Lumexa Imaging$267.73M3.38N/AN/AN/A

60.8% of SBC Medical Group shares are owned by institutional investors. 81.7% of SBC Medical Group shares are owned by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

SBC Medical Group has a net margin of 24.09% compared to Lumexa Imaging's net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Lumexa Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
Lumexa Imaging N/A N/A N/A

SBC Medical Group presently has a consensus price target of $8.50, indicating a potential upside of 176.87%. Lumexa Imaging has a consensus price target of $16.00, indicating a potential upside of 69.67%. Given SBC Medical Group's higher possible upside, equities analysts plainly believe SBC Medical Group is more favorable than Lumexa Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Lumexa Imaging
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

SBC Medical Group beats Lumexa Imaging on 7 of the 11 factors compared between the two stocks.

How does SBC Medical Group compare to Talkspace?

SBC Medical Group (NASDAQ:SBC) and Talkspace (NASDAQ:TALK) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

In the previous week, Talkspace had 7 more articles in the media than SBC Medical Group. MarketBeat recorded 7 mentions for Talkspace and 0 mentions for SBC Medical Group. SBC Medical Group's average media sentiment score of 0.00 beat Talkspace's score of -0.70 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Overall Sentiment
SBC Medical Group Neutral
Talkspace Negative

SBC Medical Group has higher earnings, but lower revenue than Talkspace. SBC Medical Group is trading at a lower price-to-earnings ratio than Talkspace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$173.61M1.81$50.99M$0.397.87
Talkspace$238.37M3.65$7.79M$0.01520.00

SBC Medical Group has a beta of 0.6, suggesting that its share price is 40% less volatile than the broader market. Comparatively, Talkspace has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

SBC Medical Group presently has a consensus target price of $8.50, suggesting a potential upside of 176.87%. Talkspace has a consensus target price of $5.56, suggesting a potential upside of 6.97%. Given SBC Medical Group's stronger consensus rating and higher possible upside, equities research analysts plainly believe SBC Medical Group is more favorable than Talkspace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Talkspace
1 Sell rating(s)
7 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

SBC Medical Group has a net margin of 24.09% compared to Talkspace's net margin of 0.49%. SBC Medical Group's return on equity of 15.90% beat Talkspace's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group24.09% 15.90% 11.61%
Talkspace 0.49%1.03%0.88%

60.8% of SBC Medical Group shares are held by institutional investors. Comparatively, 57.4% of Talkspace shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by company insiders. Comparatively, 23.5% of Talkspace shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

SBC Medical Group beats Talkspace on 11 of the 16 factors compared between the two stocks.

Get SBC Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBC vs. The Competition

MetricSBC Medical GroupMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$314.92M$8.67B$6.46B$12.11B
Dividend YieldN/A1.73%2.68%5.81%
P/E Ratio7.8723.4224.7124.00
Price / Sales1.8116.77492.4790.40
Price / Cash5.8713.9627.9237.84
Price / Book1.196.2110.826.53
Net Income$50.99M$174.80M$3.56B$336.99M
7 Day Performance2.68%2.03%1.67%-0.22%
1 Month PerformanceN/A1.54%0.43%0.77%
1 Year Performance-29.26%10.30%32.84%31.57%

SBC Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBC
SBC Medical Group
3.0546 of 5 stars
$3.07
+4.1%
$8.50
+176.9%
-31.6%$314.92M$173.61M7.87N/A
PNTG
The Pennant Group
3.8104 of 5 stars
$33.88
+2.5%
$39.00
+15.1%
+21.1%$1.18B$1.02B39.869,700
OMDA
Omada Health
2.5021 of 5 stars
$17.11
-1.3%
$22.91
+33.9%
+18.3%$1.03B$260.21MN/A849
PSNL
Personalis
1.8508 of 5 stars
$9.69
-1.0%
$11.00
+13.5%
+58.4%$1.03B$64.52MN/A400
LMRI
Lumexa Imaging
3.8774 of 5 stars
$9.03
-3.8%
$16.00
+77.2%
N/A$902.20M$267.73MN/A4,335

Related Companies and Tools


This page (NASDAQ:SBC) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners